Lymphoma

Distribution by Scientific Domains
Distribution within Medical Sciences

Kinds of Lymphoma

  • adnexal lymphoma
  • adult t-cell lymphoma
  • aggressive lymphoma
  • anaplastic large cell lymphoma
  • anaplastic large-cell lymphoma
  • angioimmunoblastic t-cell lymphoma
  • b cell lymphoma
  • b-cell lymphoma
  • b-cell non-hodgkin lymphoma
  • b-cell non-hodgkin's lymphoma
  • burkitt lymphoma
  • cd30+ anaplastic large cell lymphoma
  • cell lymphoma
  • central nervous system lymphoma
  • chronic lymphocytic small lymphocytic lymphoma
  • classical hodgkin lymphoma
  • composite lymphoma
  • cutaneous anaplastic large cell lymphoma
  • cutaneous b-cell lymphoma
  • cutaneous lymphoma
  • cutaneous t cell lymphoma
  • cutaneous t-cell lymphoma
  • diffuse large b cell lymphoma
  • diffuse large b-cell lymphoma
  • effusion lymphoma
  • extranodal lymphoma
  • extranodal marginal zone b-cell lymphoma
  • extranodal marginal zone lymphoma
  • extranodal nk/t-cell lymphoma
  • follicular lymphoma
  • gastric b-cell lymphoma
  • gastric lymphoma
  • gastric malt lymphoma
  • gland lymphoma
  • high-grade lymphoma
  • high-grade non-hodgkin's lymphoma
  • hodgkin lymphoma
  • hodgkin's lymphoma
  • human lymphoma
  • indolent b-cell lymphoma
  • indolent lymphoma
  • intraocular lymphoma
  • intravascular large b-cell lymphoma
  • intravascular lymphoma
  • killer lymphoma
  • large b cell lymphoma
  • large b-cell lymphoma
  • large cell lymphoma
  • large-cell lymphoma
  • low-grade b-cell lymphoma
  • low-grade malt lymphoma
  • lymphoblastic lymphoma
  • lymphocytic lymphoma
  • lymphocytic small lymphocytic lymphoma
  • lymphoid tissue lymphoma
  • lymphoplasmacytic lymphoma
  • malignant lymphoma
  • malt lymphoma
  • mantle cell lymphoma
  • marginal zone b-cell lymphoma
  • marginal zone lymphoma
  • mucosa-associated lymphoid tissue lymphoma
  • natural killer lymphoma
  • nervous system lymphoma
  • nk/t-cell lymphoma
  • nodal diffuse large b-cell lymphoma
  • nodal marginal zone lymphoma
  • non-hodgkin lymphoma
  • non-hodgkin's lymphoma
  • ocular adnexal lymphoma
  • other lymphoma
  • panniculitis-like t-cell lymphoma
  • peripheral t-cell lymphoma
  • plasmablastic lymphoma
  • primary central nervous system lymphoma
  • primary cutaneous anaplastic large cell lymphoma
  • primary cutaneous b-cell lymphoma
  • primary cutaneous t-cell lymphoma
  • primary effusion lymphoma
  • primary lymphoma
  • primary non-hodgkin lymphoma
  • pyothorax-associated lymphoma
  • sinonasal lymphoma
  • small lymphocytic lymphoma
  • splenic lymphoma
  • splenic marginal zone lymphoma
  • subcutaneous panniculitis-like t-cell lymphoma
  • system lymphoma
  • systemic lymphoma
  • thyroid lymphoma
  • tissue lymphoma
  • zone b-cell lymphoma
  • zone lymphoma

  • Terms modified by Lymphoma

  • lymphoma case
  • lymphoma cell
  • lymphoma cell line
  • lymphoma development
  • lymphoma diagnosis
  • lymphoma entity
  • lymphoma kinase
  • lymphoma patient
  • lymphoma presenting
  • lymphoma progression
  • lymphoma risk
  • lymphoma subtype
  • lymphoma survivor

  • Selected Abstracts


    Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus

    BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY, Issue 2 2009
    Michael D. Hammonds
    It has been suggested that up-regulation of neurotrophic and neuroprotective factors including brain-derived neurotrophic factor (BDNF) and B-cell CLL/lymphoma 2 (Bcl-2) may underlie these neuroplastic actions of the drug. Olanzapine, an atypical anti-psychotic drug, has been shown to be an effective mood stabilizer. Olanzapine also has neurotrophic and neuroprotective actions, and these actions may underlie the efficacy of the drug for bipolar disorder and schizophrenia. However, the molecular mechanism by which the drug produces the neuroplastic actions is poorly understood. To understand a common molecular mechanism underlying the neuroplastic actions of lithium and olanzapine, we assessed the effect of 4-week lithium and olanzapine treatment on the levels of BDNF, Bcl-2 and cyclic adenosine monophosphate response element-binding protein (CREB), a transcription factor involved in expression of BDNF and Bcl-2, in the dentate gyrus and hippocampal area CA1. Our results show that 4-week treatment with both olanzapine and lithium increases the levels of Bcl-2 and CREB in the dentate gyrus and hippocampal area CA1. Four-week lithium treatment up-regulates BDNF in the dentate gyrus, and 4-week olanzapine treatment marginally did so. Neither drug altered BDNF levels in area CA1. These results suggest that the up-regulation of Bcl-2 and CREB may underlie the neuroplastic actions of olanzapine and lithium. [source]


    Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis

    LIVER INTERNATIONAL, Issue 7 2007
    Xiao X. Huang
    Abstract Background/Aims: Cirrhosis can lead to hepatocellular carcinoma (HCC). Non-diseased liver and hepatitis C virus (HCV)-associated cirrhosis with or without HCC were compared. Method: Proliferation pathway genes, immune response genes and oncogenes were analysed by a quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR) and immunostaining. Results: Real-time RT-PCR showed up-regulation of genes in HCV cirrhosis including the proliferation-associated genes bone morphogenetic protein 3 (BMP3), placental growth factor 3 (PGF3), vascular endothelial growth factor receptor 1 (VEGFR1) and soluble VEGFR1, the oncogene FYN, and the immune response-associated genes toll-like receptor 9 (TLR9) and natural killer cell transcript 4 (NK4). Expressions of TLR2 and the oncogenes B-cell CLL/lymphoma 9 (BCL9) and PIM2 were decreased in HCV cirrhosis. In addition, PIM2 and TLR2 were increased in HCV cirrhosis with HCC compared with HCV cirrhosis. The ligand/receptor pair PGF and VEGFR1 was intensely expressed by the portal tract vascular endothelium. VEGFR1 was expressed in reactive biliary epithelial structures in fibrotic septum and in some stellate cells and macrophages. Conclusion: PGF and VEGFR1 may have an important role in the pathogenesis of the neovascular response in cirrhosis. [source]


    Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus

    BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY, Issue 2 2009
    Michael D. Hammonds
    It has been suggested that up-regulation of neurotrophic and neuroprotective factors including brain-derived neurotrophic factor (BDNF) and B-cell CLL/lymphoma 2 (Bcl-2) may underlie these neuroplastic actions of the drug. Olanzapine, an atypical anti-psychotic drug, has been shown to be an effective mood stabilizer. Olanzapine also has neurotrophic and neuroprotective actions, and these actions may underlie the efficacy of the drug for bipolar disorder and schizophrenia. However, the molecular mechanism by which the drug produces the neuroplastic actions is poorly understood. To understand a common molecular mechanism underlying the neuroplastic actions of lithium and olanzapine, we assessed the effect of 4-week lithium and olanzapine treatment on the levels of BDNF, Bcl-2 and cyclic adenosine monophosphate response element-binding protein (CREB), a transcription factor involved in expression of BDNF and Bcl-2, in the dentate gyrus and hippocampal area CA1. Our results show that 4-week treatment with both olanzapine and lithium increases the levels of Bcl-2 and CREB in the dentate gyrus and hippocampal area CA1. Four-week lithium treatment up-regulates BDNF in the dentate gyrus, and 4-week olanzapine treatment marginally did so. Neither drug altered BDNF levels in area CA1. These results suggest that the up-regulation of Bcl-2 and CREB may underlie the neuroplastic actions of olanzapine and lithium. [source]


    Up-regulated cytokine-inducible SH2-containing protein expression in allergen-stimulated T cells from hen's egg-allergic patients

    CLINICAL & EXPERIMENTAL ALLERGY, Issue 9 2008
    Y. Nakajima
    Summary Background Although changes in the fine balance of allergen-specific T cells are crucial in the pathogenesis of allergic diseases, their roles in the allergic reaction to hen's eggs (HE) have not yet been fully analysed. Objective Using microarray technology, allergen-stimulated T cells from HE-allergic children were analysed to identify genes that are specifically up-regulated in these cells. Methods RNA from CD4+ CD14, cells, fractionated from allergen-stimulated peripheral mononuclear cells, was analysed using a whole -genome microarray and real-time RT-PCR. The protein expression of selected genes was ascertained by flow cytometry. Results In microarray analyses of allergen-stimulated T cells, 43 genes were up-regulated in HE-allergic children but not in non-HE-allergic children. Among these, up-regulation of three genes, cytokine -inducible SH2-containing protein (CISH), nuclear factor of , light polypeptide gene enhancer in B-cell inhibitor Z (NFKBIZ) and B-cell CLL/lymphoma 2 (BCL2), was confirmed by real-time quantitative RT-PCR. CISH, but not NFKBIZ or BCL2, showed a significantly higher ratio of antigen-stimulated cell transcription over unstimulated cells in HE-allergic than in non-HE-allergic children (P<0.01). Flow-cytometric analysis revealed that the percentage of CD25+CISH+ cells in CD4+ cells from patients with HE allergy was significantly higher than that in controls (P<0.01). The expression level of CISH was significantly higher in IL-4+ Th2 cells than in IFN-,+ Th1 cells. Conclusion We noted that CISH expression in allergen-stimulated CD4+ T cells from HE-allergic patients was significantly increased in both mRNA and protein levels compared with that from non-HE-allergic children. [source]


    PARTIAL REGRESSION OF DUODENAL LESIONS OF INTESTINAL FOLLICULAR LYMPHOMA AFTER ANTIBIOTIC TREATMENT

    DIGESTIVE ENDOSCOPY, Issue 4 2010
    Tomonori Yaguchi
    A 51-year-old man was referred to our hospital because of duodenal lesions of lymphoma. Endoscopy showed multiple tiny smooth whitish granules in the second portion of the duodenum including the papilla of Vater. Biopsy specimens showed medium-sized centrocyte-like cells forming lymphoid follicles, and immunohistology showed positive staining for bcl-2 and CD10. A small bowel series showed multiple granular lesions extending from the second portion of the duodenum to the proximal jejunum and the proximal ileum. On the basis of these findings, the tumor was diagnosed as stage I follicular lymphoma (FL). Although the patient was negative for Helicobacter pylori, he underwent antibiotic treatment. The lesions improved 3 months after antibiotic treatment, but biopsy specimens showed residual lymphoma cells. The patient therefore received combination chemotherapy with rituximab. Endoscopy 4 months later showed regression of FL, and there was no evidence of recurrence during 3 years of follow up. The partial regression of duodenal lesions of intestinal FL may be due to the effect of antibiotic treatment. [source]


    NOVEL SURVEILLANCE AND CURE OF A DONOR- TRANSMITTED LYMPHOMA IN A RENAL ALLOGRAFT RECIPIENT

    NEPHROLOGY, Issue 3 2000
    Herzig Ka
    [source]


    PRIMARY NON HODGKIN'S LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM

    PATHOLOGY INTERNATIONAL, Issue 12 2001
    Robbins P
    No abstract is available for this article. [source]


    UNSPECIFIED SOLITARY PERIPHERAL T-CELL LYMPHOMA OF THE BREAST IN A TEENAGED GIRL

    PEDIATRIC DERMATOLOGY, Issue 2 2006
    Evren Sarifakioglu M.D.
    No abstract is available for this article. [source]


    A 50-YEAR-OLD MAN WITH BURKITT LYMPHOMA

    BRAIN PATHOLOGY, Issue 4 2008
    Karen SantaCruz MD
    First page of article [source]


    PREDICTIVE VALUE OF ENDOSCOPY AND ENDOSCOPIC ULTRASONOGRAPHY FOR REGRESSION OF GASTRIC DIFFUSE LARGE B-CELL LYMPHOMAS AFTER HELICOBACTER PYLORI ERADICATION

    DIGESTIVE ENDOSCOPY, Issue 4 2009
    Akira Tari
    Background:, Some gastric diffuse large B-cell lymphomas have been reported to regress completely after the successful eradication of Helicobacter pylori. The aim of this study was to investigate the clinical characteristics of gastric diffuse large B-cell lymphomas without any detectable mucosa-associated lymphoid tissue (MALT) lymphoma that went into complete remission after successful H. pylori eradication. Patients and Methods:, We examined the effect of H. pylori eradication in 15 H. pylori -positive gastric diffuse large B-cell lymphoma patients without any evidence of an associated MALT lymphoma (clinical stage I by the Lugano classification) by endoscopic examination including biopsies, endoscopic ultrasonography, computed tomography, and bone marrow aspiration. Results:,H. pylori eradication was successful in all the patients and complete remission was achieved in four patients whose clinical stage was I. By endoscopic examination, these gastric lesions appeared to be superficial. The depth by endoscopic ultrasonography was restricted to the mucosa in two patients and to the shallow portion of the submucosa in the other two patients. All four patients remained in complete remission for 7,100 months. Conclusion:, In gastric diffuse large B-cell lymphomas without a concomitant MALT lymphoma but associated with H. pylori infection, only superficial cases and lesions limited to the shallow portion of the submucosa regressed completely after successful H. pylori eradication. The endoscopic appearance and the rating of the depth of invasion by endosonography are both valuable for predicting the efficacy of H. pylori eradication in treating gastric diffuse large B-cell lymphomas. [source]


    CONCURRENT GASTRIC AND COLONIC LOW-GRADE MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMATA IN A PATIENT WITHOUT HELICOBACTER PYLORI INFECTION

    DIGESTIVE ENDOSCOPY, Issue 1 2003
    HIROYUKI OKADA
    Mucosa-associated lymphoid tissue (MALT) lymphomata observed simultaneously in the stomach and colon are rare. We report concurrent gastric and colonic low-grade MALT lymphomata that originated from the same clone in a 58-year-old Japanese man without Helicobacter pylori infection. Endoscopy showed multiple erosive lesions in the gastric body and antrum, and a single flat elevation with an irregular margin in the sigmoid colon. Histopathological findings of both lesions suggested low-grade MALT lymphoma. Lymphoepithelial lesions were evident in the gastric lesions, but not in the colonic lesion. Southern blot analysis of lymphoma cells revealed the same immunoglobulin heavy-chain rearrangement pattern. The chromosomal translocation t(11;18)(q21;q21) was also observed. After six courses of cyclophosphamide, doxorubicin, vincristine and predonisolone, the gastric lesions disappeared endoscopically, while the colonic lesion persisted. A sigmoidectomy was consequently performed. The chromosomal translocation may be related to the pathogenesis of the present MALT lymphoma case without H. pylori infection. It is interesting that the gastric and colonic lesions differed in response to treatment and in their endoscopic and histologic features, despite having the same origin. [source]


    Difficulties in diagnosing small round cell tumours of childhood from fine needle aspiration cytology samples

    CYTOPATHOLOGY, Issue 2 2008
    ekArticle first published online: 18 MAR 200, iva Pohar-Marin
    There are four basic reasons for the difficulties in diagnosing small round cell tumours (SRCT) in childhood from fine needle aspiration cytology (FNAC) samples. First, SRCTs are rare and it is difficult for cytopathologists to obtain enough experience for rendering reliable diagnoses. Second, SRCTs are morphologically very similar. Third, many SRCTs do not have specific antigens which could be demonstrated with immunocytochemistry (ICC) or they lose them when poorly differentiated. In addition, cross reactivity exists between some SRCTs. Unstandardized performance of ICC also contributes to the difficulties due to unreliable results. Fourth, suboptimal FNAC samples add additional pitfalls. The latter may be due to partly degenerate samples or to unrepresentative ones in cases where a SRCT is a heterologous component of another nosological entity. Lymphoma, neuroblastoma, nephroblastoma, Ewing's tumour/primitive neuroendocrine tumours and rhabdomyosarcoma are discussed in detail, while other less common SRCTs are mentioned as differential diagnoses when appropriate. The use of cytogenetic and molecular techniques for differentiating between certain SRCTs is helpful in some doubtful cases. However, there are still problems in the use of these techniques, especially their cost which may delay their being introduced in every cytopathology laboratory. [source]


    Immunocytochemical typing of primary tumors on fine-needle aspiration cytologies of lymph nodes

    DIAGNOSTIC CYTOPATHOLOGY, Issue 4 2008
    Alexandre Sherlley Casimiro Onofre M.Sc.
    Abstract The aim of this study was to analyze the role of immunocytochemistry as an ancillary method on routine FNACs of enlarged lymph nodes, using different markers. In a validating cohort study all patients had confirmatory histological and/or clinical follow-up. 10 FNACs were analyzed for the differentiation of Non-Hodgkin Lymphoma (NHL) from metastatic carcinoma (MC), 30 cases to identify the sites of metastatic unknown primary tumors and 16 cases were checked to confirm clinical suspicion of a specific MC. Accuracy to differentiate NHL from MC was 100%, 92.3% to identify a primary tumor site of MC, and 100% to confirm a clinical suspicion of a specific MC. In 7 cases, the site of the primary tumor remained clinically unknown. Application of immunocytochemical markers on the same slide used for microscopic diagnosis is a useful tool in the routine assessment of FNACs of lymph nodes. Diagn. Cytopathol. 2008;36:207,215. © 2008 Wiley-Liss, Inc. [source]


    Fine-needle aspiration of subcutaneous panniculitis-like T-cell lymphoma

    DIAGNOSTIC CYTOPATHOLOGY, Issue 5 2004
    Frances Manosca M.D.
    Abstract We report the fine-needle aspiration (FNA) cytology findings of Subcutaneous Panniculitis-like T-cell Lymphoma (SCPTCL) in a 66-year-old woman who presented with a four month history of asymptomatic subcutaneous nodules on her right chest wall and back. An excisional biopsy of the right chest nodules was performed, and the diagnosis of SCPTCL was rendered. On a follow-up visit, several skin lesions were noted throughout her body. A fine-needle aspiration (FNA) of the right inguinal region was performed. The FNA yielded cellular smears, composed mainly of sheets of epithelioid histiocytes and scattered multinucleated cells. However, no distinct granulomas were noted. The background of the cytological smears showed scattered atypical lymphoid cells, some of which displayed nuclear membrane irregularities. To the best of our knowledge, the cytological features on FNA material of SCPTCL have not been described. Diagn. Cytopathol. 2004;31:338,339. © 2004 Wiley-Liss, Inc. [source]


    A Case of Primary Cardiac Lymphoma: Analysis of the Role of Echocardiography in Early Diagnosis

    ECHOCARDIOGRAPHY, Issue 8 2007
    Giorgio Faganello M.D.
    Primary Cardiac Lymphoma (PCL) is defined as a non-Hodgkin's lymphoma involving only the heart and/or pericardium. Diagnosis of this rare disease is particularly difficult due to its nonspecific clinical manifestations. In this review the role of echocardiography in the early diagnosis of PCL is assessed, moreover we report an improvement in the outcome of PCL related to increased availability and utilization of echocardiography. [source]


    Resolution of a Primary Intracardiac Lymphoma

    ECHOCARDIOGRAPHY, Issue 6 2003
    Suraj Maraj
    No abstract is available for this article. [source]


    Evaluation and Management of Left Atrial Lymphoma Guided by Transesophageal Echocardiography

    ECHOCARDIOGRAPHY, Issue 6 2003
    Howard J. Willens
    A highly mobile left atrial mass was detected by transesophageal echocardiography in a patient with mediastinal lymphoma. Transesophageal echocardiography also demonstrated resolution of the mass following chemotherapy. (ECHOCARDIOGRAPHY, Volume 20, August 2003) [source]


    Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol

    EUROPEAN JOURNAL OF HAEMATOLOGY, Issue 5 2006
    Xiao-Fei Sun
    Abstract:,Objectives:,This study was designed to evaluate the efficacy and toxicity of the modified B-Non-Hodgkin's Lymphoma (NHL)-Berlin-Frankfurt-Münster (BFM)-90-based protocol in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma. Methods:,From September 1997 to August 2005, 55 untreated patients (age less than 20 yr) from a single institution were enrolled. The patients were stratified by risk factors (stage, LDH level and chemotherapy response). All patients were treated with a modified B-NHL-BFM 90 protocol. Results:,The median age of the patients was 8 yr (range 1.5,20 yr). Of these patients, 22 (40%) had Burkitt's lymphoma (BKL), 22 (40%) had diffuse large B-cell lymphoma (DLBL) and 11 (20%) had anaplastic large T-cell lymphoma (ALCL). Complete remission (CR) occurred in 45 patients (83%), partial remission (PR) in eight patients (14.5%), and progressive disease (PD) in one patient (1.8%). At a median follow up of 24 months, the event free survival (EFS) for all patients was 85% ± 5% with 100% for group R1, 84% ± 7% for group R2 and 72% ± 13% for group R3, and most notably, 80% ± 6% for stage III/IV at diagnosis. There was no statistically significant difference (P = 0.96) in EFS among BKL and DLBL and ALCL. The major toxicity complications were myelosuppression and mucositis, but these conditions were tolerated and manageable. Conclusions:,This modified NHL-BFM-90 protocol is very effective for Chinese children and adolescents with BKL and large cell lymphomas, and represented an increase in the cure rates in childhood NHL in China. [source]


    4th International Symposium on Leukemia and Lymphoma

    EUROPEAN JOURNAL OF HAEMATOLOGY, Issue 2 2000
    Molecular Pharmacology, New Treatment Modalities
    No abstract is available for this article. [source]


    Headache as the Only Presentation of Intravascular Lymphoma

    HEADACHE, Issue 4 2008
    So-Hyang Im MD
    Intravascular lymphoma (IVL) is a rare extranodal lymphoma, presenting with confusing clinical presentations and most cases have been diagnosed during the postmortem review. We report a case of IVL diagnosed by cerebrospinal fluid (CSF) examination and bone marrow biopsy in a patient with a daily headache from onset. In case of a daily headache from onset with normal neuroimagings, CSF examination may give any significant diagnostic clue and should be a consideration to exclude such causes as hematolymphoid malignancies, including the very rare IVL. [source]


    Perineural Invasion of Sinonasal Lymphoma: A Rare Cause of Trigeminal Neuropathy

    HEADACHE, Issue 2 2007
    Chih-Wei Liang MD
    Trigeminal neuropathy is characterized by sensory disturbance of the division of trigeminal nerve, and sometimes is associated with pain. Trigeminal neuropathy secondary to perineural invasion of sinonasal lymphoma is extremely rare. Likewise, sinonasal lymphoma is infrequently demonstrated initially with cranial neuropathy. The present case served to broaden the differential diagnosis of secondary trigeminal neuropathy and to alert clinicians to cautiously assess perineural spread of occult neoplasm in sinonasal tract and larynx or pharynx for cases with evolving trigeminal neuropathy or even other cranial nerve neuropathy in which no definite cause is identified. [source]


    Serum Antibodies to Helicobacter pylori and its Heat-Shock Protein 60 Correlate with the Response of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma to Eradication of H. pylori

    HELICOBACTER, Issue 3 2004
    Ryuta Takenaka
    ABSTRACT Background and aims., Eradication of Helicobacter pylori leads to regression of mucosa-associated lymphoid tissue (MALT) lymphomas. In this study, we measured serum antibodies to H. pylori and H. pylori- recombinant heat-shock protein 60 (rHSP60) in patients with gastric MALT lymphoma to determine whether humoral immune responses to the bacterial antigens correlate with the efficacy of eradication therapy. Methods., Serum samples were obtained from 33 patients with H. pylori -positive gastric MALT lymphoma before undergoing therapy to eradicate the bacteria. Anti- H. pylori antibodies were measured in a commercial assay and in immunoassays to lysates and rHSP60 which were prepared from ATCC 43504 strain. Results.,Helicobacter pylori were eradicated in all 33 patients, and the lymphoma completely regressed histologically in 26 patients (79%). Pre-treatment titers of serum antibody to H. pylori and to rHSP60 in the patients whose tumor regressed were significantly higher than titers in patients whose tumors did not regress (p = .0011 and .035, respectively). By logistic regression analysis, age (odds ratio = 0.88, 95% confidence interval = 0.80,0.99), endoscopic appearance (0.053, 0.004,0.65), titers of anti- H. pylori antibodies (67.6, 2.5,1800), and titers of anti-rHSP60 antibody (6.4, 1.2,36) were identified as significantly associated factors with the outcome of MALT lymphoma. Conclusions., Measurement of serum antibodies to H. pylori and HSP60 might be useful for predicting the response of gastric MALT lymphoma to eradication of H. pylori. [source]


    Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach

    HEMATOLOGICAL ONCOLOGY, Issue 4 2009
    Cristiana Bellan
    Abstract Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tumours as an "aggressive B-cell non-Hodgkin's lymphoma", characterized by a high degree of proliferation of the malignant cells and deregulation of the c- MYC gene. The main diagnostic challenge in BL is to distinguish it from diffuse large B-cell lymphoma (DLBCL). While in children BL and DLBCL types probably do not differ clinically, and the differential diagnosis between BL and DLBCL may theoretically appear clear-cut, in adults daily practice shows the existence of cases that have morphological features, immunophenotypic and cytogenetics intermediate between DLBCL and BL, and cannot be classified with certainty in these categories. Distinguishing between BL and DLBCL is critical, as the two diseases require different management. This review summarizes the current practical approach, including the use of a large panel of antibodies, and cytogenetic and molecular diagnostic techniques, to distinguish between BL, DLBCL and the provisional category of "B-cell lymphoma, unclassificable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma", now listed in the updated WHO classification. Copyright © 2009 John Wiley & Sons, Ltd. [source]


    Low dose 2-CdA schedule activity in splenic marginal zone lymphomas

    HEMATOLOGICAL ONCOLOGY, Issue 4 2003
    R. Riccioni
    Abstract Splenic Marginal Zone Lymphoma (SMZL) is a rare clinicopathological entity among marginal zone lymphomas. SMZL is an indolent lymphoma usually treated by splenectomy. A subset of patients is characterized by a more aggressive clinical course and poor prognosis. Treatment of these cases and second-line therapy for relapsed patients have not been yet identified. We report 10 cases treated with cladribrine (5,mg/m2/week) for six courses. Six patients (60%) achieved partial response, two patients (20%) achieved a complete response and the two remaining patients did not respond and died as a result of progression of the disease. The treatment was well tolerated. A total of 60% of the patients had an overall survival rate of 48 months and 24 months progression-free-survival was achieved by 37% with a median time of progression-free-survival of 17 months. Interestingly, in addition to a relevant percentage of hematological remission, some patients also experienced a molecular remission. We conclude that this treatment is safe and well tolerated and is able to induce a substantial number of responses. Our results suggest that this schedule is well tolerated and could be an useful alternative to splenectomy. Copyright © 2003 John Wiley & Sons, Ltd. [source]


    An Illustrated Guide to Skin Lymphoma

    HISTOPATHOLOGY, Issue 3 2000
    Blackwell Science, Helmut Kerl, ISBN 0-632-05082-, Kevin Gatter, Lorenzo Cerroni, Oxford
    No abstract is available for this article. [source]


    Secondary Syphilis Presenting as Cutaneous T-Cell Lymphoma in an HIV-Positive Patient

    JOURNAL OF CUTANEOUS PATHOLOGY, Issue 1 2005
    A. Laungani
    We present the case of an HIV-positive 38-year-old Caucasian male with a history of fevers, chills, and disseminated nonpruritic erythematous papules that began on his abdomen. An initial skin biopsy revealed a lymphohistiocytic infiltrate at the dermoepidermal junction, exocytosis of atypical lymphocytes, and minimal spongiosis. Immunohistochemistry showed increased CD8-positive cells but only scattered CD30-positive cells. PCR analysis demonstrated T-cell receptor gamma gene rearrangement. RPR, blood and tissue cultures were all negative. The patient was thought to have a cytotoxic cutaneous T-cell lymphoma. Over time, the lesions progressed to the palms and soles and the patient remained febrile. Repeat biopsy demonstrated a lichenoid interface dermatitis with a superficial and deep perivascular, interstitial, and periadnexal lymphohistiocytic infiltrate and the formation of epithelioid granulomas throughout the dermis. The epidermis showed blurring of the dermoepidermal junction, spongiosis, and exocytosis of lymphocytes and neutrophils. Few spirochetes were demonstrated by Steiner stain. Repeat RPR and FTA-Abs serologies were positive. The patient was diagnosed with late secondary syphilis and was successfully treated with benzathine penicillin. This case demonstrates that atypical lymphoid infiltrates can simulate mycosis fungoides in an HIV-positive patient with secondary syphilis and also reiterates that syphilis is a great mimicker of other entities. [source]


    Lymphomatoid Papulosis Presenting With B-Cell Lymphoma: A New Association?

    JOURNAL OF CUTANEOUS PATHOLOGY, Issue 1 2005
    A. Galan
    Lymphomatoid papulosis (LyP) is a cutaneous T-cell lymphoproliferative disorder, characterised by recurrent crops of necrotic self-healing papules and nodules. Although chronic, LyP typically has a benign clinical course in the majority of cases. Histologically, a malignant appearing T-cell lymphoid infiltrate is seen. The atypical cells often resemble the cerebriform cells of mycosis fungoides or Reed-Sternberg cells in Hodgkin lymphoma. Approximately 10,20% of the patients go on to develop lymphomas, including mycosis fungoides, CD30-positive anaplastic large cell and Hodgkin lymphoma. We report a case of LyP associated with a B-cell lymphoma. A 50-year-old male, presented with scattered erythematous scaly papules, some with central crust, located on the arms, trunk and leg of one-month duration. A skin biopsy revealed a polymorphous infiltrate with many large atypical lymphocytes, resembling Reed Sternberg cells. By immunohistochemistry, the large cells were positive for T-cell markers and CD30. Subsequently, he developed fever, night sweats and diffuse lymphadenopathy. A lymph node biopsy showed a vaguely nodular proliferation of small to medium lymphocytes. Immunophenotypic and flow cytometric studies best characterised the process as mantle cell lymphoma. Although, LyP has been previously associated with lymphomas of above-mentioned types, this is an extremely unusual case presenting with a low-grade B-cell lymphoma. [source]


    Fatal Subcutaneous Panniculitis-Like T-Cell Lymphoma (Sptcl) with Interface Change and Dermal Mucin, A Dead-Ringer for Lupus Erythematosus

    JOURNAL OF CUTANEOUS PATHOLOGY, Issue 1 2005
    L. Ma
    We report a 48-year-old male who presented with ulcerated plaques and nodules of the lower extremities. Skin biopsies revealed a dense lymphocytic infiltrate involving the dermis and the subcutis in a lobular and septal pattern. No overt cytological atypia was present. Notably, several features resembling lupus erythematosus were present, including vacuolar interface change and abundant dermal mucin deposition. The patient developed pulmonary nodules, and a lung biopsy showed a perivascular and interstitial lymphoid infiltrate without overt atypia. The cutaneous and pulmonary lymphoid infiltrates showed similar immunohistochemical profiles: CD3+CD4,CD8+/,CD56+. Monoclonal rearrangements of T-cell receptor gamma gene with similar migration patterns were identified from both locations. The patient developed fatal hemophagocytic syndrome, involving liver, spleen, lymph nodes, and bone marrow. This case is amongst rare reports of subcutaneous panniculitis-like T-cell Lymphoma (SPTCL) with systemic involvement. [source]


    Primary Non-Hodgkin Lymphoma of the Skull Base Presenting with Garcin Syndrome: MRI Manifestations

    JOURNAL OF NEUROIMAGING, Issue 3 2009
    Ayami Nakamura MD
    ABSTRACT Primary non-Hodgkin lymphoma of the skull base is a rare disorder. We report a case of primary non-Hodgkin lymphoma of the skull base presenting with Garcin syndrome. MRI revealed peculiar lesions in the cavernous sinus, clivus, and occipital bone. Diagnosis was made by biopsy of the tumor in the cavernous sinus. [source]


    Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites

    JOURNAL OF ORAL PATHOLOGY & MEDICINE, Issue 4 2010
    Avraham Zini
    J Oral Pathol Med (2010) 39: 299,305 Background:, Oral cancer is one of the few life-threatening oral diseases. The subtypes and different sites of oral cancer has different etiology epidemiology and survival rate. Prevalence of the various anatomical oral sites provided potential baseline for improvement of clinical approach. Methods:, Incidence and survival rates were derived from the Israel National Cancer Registry and included all registered data between 1970 and 2006. Oral cancer included the lips, tongue, buccal mucosa, gums, vestibulum, floor of the mouth, and palate. Results:, Most prevalent oral cancer subtype was squamous cell carcinoma (SCC) among men above the age of 55 years. Females had a higher incidence of SCC in lateral border of tongue, gums and buccal mucosa. Lymphoma and sarcoma were the most prevalent under the age of 20. Melanomas and metastatic disease revealed the lowest survival rate, while invasive or infiltrating basal cell carcinoma in the lips had the highest rate. The highest oral survival rate was for the lip, and the lowest was for the tongue and gums. Conclusions:, Early detection of oral cancer is important for all the medical health team. Decrease in lip carcinoma may be a result of occupational or awareness changes and should be studied. Non-epithelial tumors under the age of 20 should be considered as a differential diagnosis. A basic oral examination should be included in all routine medical examinations, with emphasis on high-risk patients and high-risk oral sites. [source]